Literature DB >> 16157129

Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition.

Soo-Young Oh1, Chong Jai Kim, Insuk Park, Roberto Romero, Yoo-Kyung Sohn, Kyung Chul Moon, Bo Hyun Yoon.   

Abstract

OBJECTIVE: The role of progesterone in the control of human parturition remains unsettled. Because there is no systemic progesterone withdrawal before the onset of labor, a 'functional progesterone withdrawal' has been proposed to be operative before human parturition. This may be accomplished by a change in the density of the progesterone receptor (PR) isoforms in myometrium and fetal membranes. The purpose of our study was to determine if spontaneous term labor is associated with changes of PR isoforms (PR-A and PR-B) in the fetal membranes. STUDY
DESIGN: Fetal membranes were obtained from women undergoing elective cesarean delivery at term (not in labor group), and from women with a vaginal delivery (labor group). The expression of PR isoforms was assessed by Western blot analysis of amnion and chorio-decidua. Densitometric analysis of PR-A/PR-B ratio was performed. Immunohistochemistry with specific antibodies to PR-A and PR-B was done. Nonparametric statistics were used for analysis.
RESULTS: 1) The predominant isoform of PR in women not in labor was PR-B, and PR-A in patients in labor. The ratio of PR-A/PR-B in fetal membranes was significantly higher in women in labor than in those not in labor (for amnion, median 4.3, range [0.9-8.4] vs median 0.4, range [0.3-2.6], P < .001; for chorio-decidua, median 2.0, range [1.1-19.2] vs median 1.2, range [0.1-2.0], P < .05). 2) Fetal membranes expressed both types of PR. 3) Immunohistochemistry showed the presence of PR-A and PR-B in the cytoplasm of amnion epithelial cells, chorion trophoblast, and decidual cells.
CONCLUSION: Human parturition at term is associated with changes in PR isoforms in the fetal membranes and, thus, a local 'functional progesterone withdrawal' may operate in human parturition through this mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157129     DOI: 10.1016/j.ajog.2005.05.071

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

Review 1.  Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.

Authors:  Roberto Romero; Kypros Nicolaides; Agustin Conde-Agudelo; Ann Tabor; John M O'Brien; Elcin Cetingoz; Eduardo Da Fonseca; George W Creasy; Katharina Klein; Line Rode; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2011-12-11       Impact factor: 8.661

2.  Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term.

Authors:  Pooja Mittal; Roberto Romero; Adi L Tarca; Juan Gonzalez; Sorin Draghici; Yi Xu; Zhong Dong; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; Stephen Lye; Juan Pedro Kusanovic; Leonard Lipovich; Shali Mazaki-Tovi; Sonia S Hassan; Sam Mesiano; Chong Jai Kim
Journal:  J Perinat Med       Date:  2010-07-14       Impact factor: 1.901

3.  Amnion epithelial cell-derived exosomes induce inflammatory changes in uterine cells.

Authors:  Emily E Hadley; Samantha Sheller-Miller; George Saade; Carlos Salomon; Sam Mesiano; Robert N Taylor; Brandie D Taylor; Ramkumar Menon
Journal:  Am J Obstet Gynecol       Date:  2018-08-21       Impact factor: 8.661

4.  Progesterone receptor membrane components: key regulators of fetal membrane integrity.

Authors:  Violetta Lozovyy; Lauren Richardson; George Saade; Ramkumar Menon
Journal:  Biol Reprod       Date:  2021-02-11       Impact factor: 4.285

5.  Progesterone supplementation and the prevention of preterm birth.

Authors:  Errol R Norwitz; Aaron B Caughey
Journal:  Rev Obstet Gynecol       Date:  2011

6.  Induction of G protein-coupled estrogen receptor (GPER) and nuclear steroid hormone receptors by gonadotropins in human granulosa cells.

Authors:  Roman Pavlik; Gabriela Wypior; Stefanie Hecht; Panos Papadopoulos; Markus Kupka; Christian Thaler; Irmi Wiest; Aurelia Pestka; Klaus Friese; Udo Jeschke
Journal:  Histochem Cell Biol       Date:  2011-08-02       Impact factor: 4.304

Review 7.  Progesterone to prevent spontaneous preterm birth.

Authors:  Roberto Romero; Lami Yeo; Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  Semin Fetal Neonatal Med       Date:  2013-12-05       Impact factor: 3.926

8.  Polymorphisms in the fetal progesterone receptor and a calcium-activated potassium channel isoform are associated with preterm birth in an Argentinian population.

Authors:  P C Mann; M E Cooper; K K Ryckman; B Comas; J Gili; S Crumley; E N A Bream; H M Byers; T Piester; A Schaefer; P J Christine; A Lawrence; K L Schaa; K J P Kelsey; S K Berends; A M Momany; E Gadow; V Cosentino; E E Castilla; J López Camelo; C Saleme; L J Day; S K England; M L Marazita; J M Dagle; J C Murray
Journal:  J Perinatol       Date:  2012-09-27       Impact factor: 2.521

9.  Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo.

Authors:  Mark A Klebanoff; Paul J Meis; Mitchell P Dombrowski; Yuan Zhao; Atef H Moawad; Allison Northen; Baha M Sibai; Jay D Iams; Michael W Varner; Steve N Caritis; Mary J O'Sullivan; Kenneth J Leveno; Menachem Miodovnik; Deborah Conway; Ronald J Wapner; Marshall Carpenter; Brian M Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman
Journal:  Am J Obstet Gynecol       Date:  2008-05-23       Impact factor: 8.661

10.  Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth.

Authors:  Nicole L Ehn; Margaret E Cooper; Kristin Orr; Min Shi; Marla K Johnson; Diana Caprau; John Dagle; Katherine Steffen; Karen Johnson; Mary L Marazita; David Merrill; Jeffrey C Murray
Journal:  Pediatr Res       Date:  2007-11       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.